These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10763837)

  • 1. Serum concentrations of soluble Fas antigen and soluble Fas ligand in mother and newborn.
    Iwama H; Akutsu H; Kuretake S; Tohma J; Nakamura N
    Arch Gynecol Obstet; 2000 Feb; 263(3):108-10. PubMed ID: 10763837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Fas antigen and soluble Fas ligand in early neonatal life.
    Sarandakou A; Protonotariou E; Rizos D; Soubassi L; Malamitsi-Puchner A
    Early Hum Dev; 2003 Dec; 75(1-2):1-7. PubMed ID: 14652155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of soluble concentration Fas and Fas ligand in maternal and cord blood 3rd trimester of pregnancy.
    Karowicz-Bilińska A; Kowalska-Koprek U; Estemberg D; Sikora-Szubert A
    Ginekol Pol; 2018; 89(3):142-146. PubMed ID: 29664549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum soluble Fas in the syndrome of hemolysis, elevated liver enzymes, and low platelets.
    Harirah H; Donia SE; Hsu CD
    Obstet Gynecol; 2001 Aug; 98(2):295-8. PubMed ID: 11506848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas and Fas ligand expression in maternal blood and in umbilical cord blood in preeclampsia.
    Kuntz TB; Christensen RD; Stegner J; Duff P; Koenig JM
    Pediatr Res; 2001 Dec; 50(6):743-9. PubMed ID: 11726734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of cotinine level in amniotic fluid, umbilical artery blood and maternal blood].
    Rühle W; Graf von Ballestrem CL; Pult HM; Gnirs J
    Geburtshilfe Frauenheilkd; 1995 Mar; 55(3):156-9. PubMed ID: 7665063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration of malondialdehyde (MDA) in amniotic fluid and maternal and cord serum in cases of intrauterine growth retardation.
    Bazowska G; Jendryczko A
    Zentralbl Gynakol; 1994; 116(6):329-30. PubMed ID: 8048286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of serum soluble Fas/soluble Fas ligand and TNF-alpha on response to interferon-alpha therapy in chronic hepatitis C.
    Toyoda M; Kakizaki S; Horiguchi N; Sato K; Takayama H; Takagi H; Nagamine T; Mori M
    Liver; 2000 Jul; 20(4):305-11. PubMed ID: 10959809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental transport of bile acids: analysis of bile acids in maternal serum and urine, umbilical cord blood, and amniotic fluid.
    Ushijima K; Kimura A; Inokuchi T; Yamato Y; Maeda K; Yamashita Y; Nakashima E; Kato H
    Kurume Med J; 2001; 48(2):87-91. PubMed ID: 11501503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of soluble Fas in maternal serum and amniotic fluid during uncomplicated pregnancies.
    Malamitsi-Puchner A; Sarandakou A; Papagianni V; Protonotariou E; Tziotis J; Botsis D
    J Soc Gynecol Investig; 2003 Apr; 10(3):158-60. PubMed ID: 12699879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detectable concentrations of Fas ligand in cerebrospinal fluid after severe head injury.
    Ertel W; Keel M; Stocker R; Imhof HG; Leist M; Steckholzer U; Tanaka M; Trentz O; Nagata S
    J Neuroimmunol; 1997 Dec; 80(1-2):93-6. PubMed ID: 9413263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of soluble Fas (sFas) and soluble Fas ligand (sFasL) in patients with burns.
    Yamada Y; Endo S; Nakae H; Makabe H; Sato N; Wakabayashi G; Kitamura M; Inada K; Sato S
    Burns; 2003 Dec; 29(8):799-802. PubMed ID: 14636754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in advanced melanoma.
    Mouawad R; Khayat D; Soubrane C
    Melanoma Res; 2000 Oct; 10(5):461-7. PubMed ID: 11095407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble fas antigen and soluble fas ligand in intrauterine growth restriction.
    Briana DD; Baka S; Boutsikou M; Liosi S; Vraila VM; Gourgiotis D; Hassiakos D; Malamitsi-Puchner A
    Neonatology; 2010; 97(1):31-5. PubMed ID: 19590243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a suppression of apoptosis in early postnatal life.
    Malamitsi-Puchner A; Sarandakou A; Tziotis J; Trikka P; Creatsas G
    Acta Obstet Gynecol Scand; 2001 Nov; 80(11):994-7. PubMed ID: 11703194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases.
    Nozawa K; Kayagaki N; Tokano Y; Yagita H; Okumura K; Hasimoto H
    Arthritis Rheum; 1997 Jun; 40(6):1126-9. PubMed ID: 9182923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations of leptin and neuropeptide Y in maternal plasma, umbilical cord blood and in amniotic fluid in pregnant women with EPH-gestosis.
    Kokot F; Ulman I; Wiecek A; Irzyniec T; Ulman J
    Arch Immunol Ther Exp (Warsz); 1998; 46(5):311-6. PubMed ID: 9832071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Fas may be a proinflammatory marker after cardiopulmonary bypass in children.
    Joashi U; Tibby SM; Turner C; Mayer A; Austin C; Anderson D; Durward A; Murdoch IA
    J Thorac Cardiovasc Surg; 2002 Jan; 123(1):137-44. PubMed ID: 11782767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine in pregnancy - therapeutic drug monitoring in maternal blood, amniotic fluid, and cord blood.
    Paulzen M; Lammertz SE; Veselinovic T; Goecke TW; Hiemke C; Gründer G
    Int Clin Psychopharmacol; 2015 Sep; 30(5):249-54. PubMed ID: 26086711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-G antigen and parturition: maternal serum, fetal serum and amniotic fluid levels during pregnancy.
    Hackmon R; Hallak M; Krup M; Weitzman D; Sheiner E; Kaplan B; Weinstein Y
    Fetal Diagn Ther; 2004; 19(5):404-9. PubMed ID: 15305096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.